[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-337400-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-337400-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","exploring-the-potential-of-montmorillonite-as-an-antiproliferative-nanoagent-against-mda-mb-231-and-mcf-7-human-breast-cancer-cells","Exploring the Potential of Montmorillonite as an Antiproliferative Nanoagent against MDA-MB-231 and MCF-7 Human Breast Cancer Cells","","Unlike MCF-7 cells, MDA-MB-231 cells are resistant to hormone therapy and often withstand chemotherapy and radiotherapy. This study evaluated the antiproliferative effect of biocompatible montmorillonite (Mt) nanosheets on both cell lines using MTT, flow cytometry, and qRT-PCR. Mt produced apoptosis and cell-cycle disturbances, with IC50 values and gene-regulation patterns varying by serum conditions. MDA-MB-231 showed higher vulnerability to Mt, suggesting utility for local nanoparticle-based therapy.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/exploring-the-potential-of-montmorillonite-as-an-antiproliferative-nanoagent-against-mda-mb-231-and-mcf-7-human-breast-cancer-cells/337400/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/exploring-the-potential-of-montmorillonite-as-an-antiproliferative-nanoagent-against-mda-mb-231-and-mcf-7-human-breast-cancer-cells/337400.png","ImageObject",300,407,{"name":42,"@type":43},"Logic","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-24","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",12,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"Why were MDA-MB-231 and MCF-7 cells compared in this study?","Question",{"text":63,"@type":64},"They differ in proliferation and metastasis behavior and in their response to therapy. MDA-MB-231 is more aggressive and often resistant to hormone therapy, chemotherapy, and radiotherapy, while MCF-7 responds to hormone therapy and is non-metastatic.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How was the antiproliferative effect of montmorillonite (Mt) assessed?",{"text":68,"@type":64},"The study used MTT assay, flow cytometry, and qRT-PCR to evaluate antiproliferative activity, cell death, and gene expression changes after Mt treatment.",{"name":70,"@type":61,"acceptedAnswer":71},"What cellular effects did Mt induce in the two breast cancer cell lines?",{"text":72,"@type":64},"Mt induced apoptosis in both cell types through regulation of apoptosis- and related genes. It also caused cell-cycle arrest, including G0/G1 arrest in MCF-7 and sub-G1 arrest and necrosis in both cells, consistent with mitochondrial damage.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},337400,1790158686,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":55,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":113,"preview_page_count":33,"preview_urls":145},1099513958762,"https://ap-avatar.wpscdn.com/avatar/1000023916a998db790?x-image-process=image/resize,m_fixed,w_180,h_180&k=1784791008015729253","cells  \nArticle  \nExploring the Potential of Montmorillonite as an Antiproliferative Nanoagent against MDA-MB-231 and MCF-7 Human Breast Cancer Cells  \nAlireza Ghannad Sabzevari 1, Hossein Sabahi 2, Mohsen Nikbakht 3,*, Mehdi Azizi 1,  \nHassan Dianat-Moghadam 4,5 and Zohreh Amoozgar 6, *  \nCitation: Sabzevari, A.G.; Sabahi, H.; Nikbakht, M.; Azizi, M.; DianatMoghadam, H.; Amoozgar, Z. Exploring the Potential of Montmorillonite as an Antiproliferative Nanoagent against MDA-MB-231 and MCF-7 Human Breast Cancer Cells. Cells 2024, 13, 200 . [https://doi.org/10.3390/cells13020200](https://doi.org/10.3390/cells13020200)  \nAcademic Editor: Karuppusamy Shanmugapriya  \nReceived: 19 November 2023  \nRevised: 10 January 2024  \nAccepted: 18 January 2024  \nPublished: 22 January 2024  \nCopyright: © 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://](https://)[ ](https://)[creativecommons.org/licenses/by/](creativecommons.org/licenses/by/)[ ](creativecommons.org/licenses/by/)[4.0/](4.0/)) .  \n1 Department of Tissue Engineering and Biomaterials, Faculty of Advanced Medical Sciences and Technologies, Hamadan University of Medical Sciences, Hamadan 6517838736, Iran; [ghannad@umsha.ac.ir](ghannad@umsha.ac.ir) (A.G.S.); [mehdi.azizi6815@gmail.com](mehdi.azizi6815@gmail.com) (M.A.)  \n2 Department of Life Science Engineering, Faculty of New Sciences and Technologies, University of Tehran, Tehran 1439957131, Iran; [hsabahi@ut.ac.ir](hsabahi@ut.ac.ir)  \n3 Hematology Oncology and Stem Cell Transplantation Research Center, Tehran University of Medical Sciences, Tehran 1411713135, Iran  \n4 Department of Genetics and Molecular Biology, School of Medicine, Isfahan University of Medical Sciences, Isfahan 8174673461, Iran; [dianat.h@med.mui.ac.ir](dianat.h@med.mui.ac.ir)  \n5 Pediatric Inherited Diseases Research Center, Isfahan University of Medical Sciences, Isfahan 8174673461, Iran  \n6 Edwin L. Steele Laboratories for Tumor Biology, Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA  \n* [Correspondence: m-nikbakht@sina.tums.ac.ir](Correspondence: m-nikbakht@sina.tums.ac.ir) (M.N.); [zamoozgar@mgh.harvard.edu](zamoozgar@mgh.harvard.edu) (Z.A.)  \nAbstract: Unlike MCF-7 cells, MDA-MB-231 cells are unresponsive to hormone therapy and often show resistance to chemotherapy and radiotherapy. Here, the antiproliferative effect of biocompatible montmorillonite (Mt) nanosheets on MDA-MB-231 and MCF-7 human breast cancer cells was evaluated by MTT assay, flow cytometry, and qRT-PCR. The results showed that the Mt IC50 for MDA-MB-231 and MCF-7 cells in a fetal bovine serum (FBS)-free medium was ~50 and ~200 µg/mL, and in 10% FBS medium ~400 and ~2000 µg/mL, respectively. Mt caused apoptosis in both cells by regulating related genes including Cas-3, P53, and P62 in MDA-MB-231 cells and Bcl-2, Cas-8, Cas-9, P53, and P62 in MCF-7 cells. Also, Mt arrested MCF-7 cells in the G0/G1 phase by altering Cyclin-D1 and P21 expression, and caused sub-G1 arrest and necrosis in both cells, possibly through damaging the mitochondria. However, fewer gene expression changes and more sub-G1 arrest and necrosis were observed in MDA-MB-231 cells, confirming the higher vulnerability of MDA-MB-231 cells to Mt. Furthermore, MDA-MB-231 cells appeared to be much more vulnerable to Mt compared to other cell types, including normal lung fibroblast (MRC-5), colon cancer (HT-29), and liver cancer (HepG2) cells. The higher vulnerability of MDA-MB-231 cells to Mt was inferred to be due to their higher proliferation rate. Notably, Mt cytotoxicity was highly dependent on both the Mt concentration and serum level, which favors Mt for the local treatment of MDA-MB-231 cells. Based on these results, Mt can be considered as an antiproliferative nanoagent against MDA-MB-231 cells and may be usefu","cbCaisvmsNt3ZYxk","https://ap.wps.com/l/cbCaisvmsNt3ZYxk","pdf",1159710,"English","# Abstract\n# Introduction","[{\"question\":\"Why were MDA-MB-231 and MCF-7 cells compared in this study?\",\"answer\":\"They differ in proliferation and metastasis behavior and in their response to therapy. MDA-MB-231 is more aggressive and often resistant to hormone therapy, chemotherapy, and radiotherapy, while MCF-7 responds to hormone therapy and is non-metastatic.\"},{\"question\":\"How was the antiproliferative effect of montmorillonite (Mt) assessed?\",\"answer\":\"The study used MTT assay, flow cytometry, and qRT-PCR to evaluate antiproliferative activity, cell death, and gene expression changes after Mt treatment.\"},{\"question\":\"What cellular effects did Mt induce in the two breast cancer cell lines?\",\"answer\":\"Mt induced apoptosis in both cell types through regulation of apoptosis- and related genes. It also caused cell-cycle arrest, including G0/G1 arrest in MCF-7 and sub-G1 arrest and necrosis in both cells, consistent with mitochondrial damage.\"}]","Exploring the Potential of Montmorillonite as an Antiproliferative Nanoagent against MDA-MB-231 and MCF-7 Human Breast Cancer Cells | PDF",1790018985,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f4d5df49e5f5fbfac46a13dfbb53ddeb.webp",983,1390,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ed6a01718ea08f8f78bbed0b5e52354f.webp",982,1388,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/60aca5569b9e809f2e23231658a009d1.webp",981,1387,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b7d3ea2893fec15589ee28bbc14326e2.webp",980,1385]